US and French researchers have found a gene, called UCP2, which could becentral to the control of the deposition of body fat, according to Nature Genetics (March issue).
The gene codes for uncoupling protein 2, and is present in all tissues and at high levels in white adipose tissue and muscle. Drug companies are already working on another gene target, UCP1, but this is only present in brown fat, which is sparse in adults. There is evidence that UCP2 is underactive in a strain of obesity-prone mice compared to a lean strain.
Drug firms "are hovering like vultures over the finding," according to one obesity researcher.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze